Literature DB >> 3320207

A comparison of spleen and lymph node cells as fusion partners for the raising of monoclonal antibodies after different routes of immunisation.

I H Mirza1, T J Wilkin, M Cantarini, K Moore.   

Abstract

Administration of antigen (human insulin) via the rear footpads of BALB/c mice with subsequent fusion of popliteal and inguinal lymph node lymphocytes induced a higher frequency of hybridomas (100%) secreting specific antibody than either intradermal immunisation and lymph node cell fusion (53%) or conventional subcutaneous immunisation and intraperitoneal boost followed by splenic lymphocyte fusion (8%). The rank order of serum antibody titres was found to correlate with the order of fusion efficiencies. Lymph node cell fusions also produced a greater spectrum of antibody specificities. Such differences in fusion efficiencies were also observed using bovine intestinal alkaline phosphatase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3320207     DOI: 10.1016/0022-1759(87)90271-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Comparing CDRH3 diversity captured from secondary lymphoid organs for the generation of recombinant human antibodies.

Authors:  Sophie Venet; Marie Kosco-Vilbois; Nicolas Fischer
Journal:  MAbs       Date:  2013-07-02       Impact factor: 5.857

2.  Expression of two bovine rotavirus non-structural proteins (NSP2, NSP3) in the baculovirus system and production of monoclonal antibodies directed against the expressed proteins.

Authors:  C Aponte; N M Mattion; M K Estes; A Charpilienne; J Cohen
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Insulin autoantibody polymorphisms with greater discrimination for diabetes in humans.

Authors:  T Wilkin; I Mirza; M Armitage; C Casey; L Scott-Morgan
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

4.  Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses.

Authors:  Tilo Senger; Maria R Becker; Lysann Schädlich; Tim Waterboer; Lutz Gissmann
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

5.  Lymphocytes from enlarged iliac lymph nodes as fusion partners for the production of monoclonal antibodies after a single tail base immunization attempt.

Authors:  Yoshikazu Sado; Satoko Inoue; Yasuko Tomono; Hiroyuki Omori
Journal:  Acta Histochem Cytochem       Date:  2006-04-26       Impact factor: 1.938

6.  Construction of a bovine-murine heteromyeloma cell line; production of bovine monoclonal antibodies against rotavirus and pregnant mare serum gonadotrophin.

Authors:  P Booman; M Tieman; D Van Zaane; A A Bosma; G F De Boer
Journal:  Vet Immunol Immunopathol       Date:  1990-03       Impact factor: 2.046

7.  A recombinant O-polysaccharide-protein conjugate approach to develop highly specific monoclonal antibodies to Shiga toxin-producing Escherichia coli O157 and O145 serogroups.

Authors:  Daniela S Castillo; Diego A Rey Serantes; Luciano J Melli; Andrés E Ciocchini; Juan E Ugalde; Diego J Comerci; Alejandro Cassola
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.